Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Advanced melanoma, metastatic non-small cell lung cancer, malignant pleural mesothelioma, advanced renal cell carcinoma, classical Hodgkin lymphoma, squamous cell carcinoma of the head and neck, urothelial carcinoma, and MSI-H/dMMR metastatic colorectal cancer.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.
EGFR-mutated Non-Small Cell Lung Cancer (NSCLC).
Testicular, Ovarian, Bladder, Lung, Colorectal, Gastric, and Head & Neck Cancers.